首頁 > 市場調查報告書 > 製藥

再生醫學

市場調查報告書

商品編碼

2084875

人工精子市場：按應用、最終用戶和地區分類

Artificial Sperm Market, By Application (Artificial Insemination, Azoospermia, and Others), By End User (Hospital, Fertility Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

出版日期: 2026年06月04日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，人工精子市場規模將達26億美元，2033年將達到42億美元。預計從2026年到2033年，其複合年成長率將達到7.1%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	26億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.10%	2033年市場規模預測：	42億美元

受全球不孕症盛行率上升、輔助生殖技術（ART）普及、不孕症治療需求成長、生育年齡趨於晚年以及生殖生物技術和再生醫學不斷進步等因素的推動，該市場正在經歷顯著成長。

人工精子技術是生殖醫學領域的新興方向，其核心在於利用幹細胞技術和先進的實驗室技術培養功能性精子細胞。這項技術有望解決嚴重的男性不孕症，例如無精子症和精子發生障礙，而這些疾病目前尚無法透過傳統的生育療法有效治療。增加對幹細胞研究和生殖遺傳學領域的投入，正在加速科學進步，並擴展未來的商業化機會。

體外受精（IVF）、人工授精和其他輔助生殖技術（ART）的日益普及，為人工精子技術的發展創造了有利環境。根據國際輔助生殖技術監測委員會（ICMART）統計，全球每年有超過1,300萬個嬰兒透過體外受精出生，凸顯了生殖技術在不孕症治療中日益重要的角色。此外，生育診所的擴張、醫療保健支出的成長以及生育支持計畫的完善，預計將在預測期內進一步加速市場成長。

市場動態

人工精子市場正經歷強勁成長，這主要受人口、臨床和技術等多方面因素的驅動。其中一個主要促進因素是全球不孕症負擔日益加重。世界衛生組織（WHO）的數據顯示，全球約有17.5%的成年人在其一生中的某個階段會經歷不孕不育，相當於近六分之一的人口。男性和女性不孕症盛行率的不斷上升，持續推動對先進生殖健康解決方案的需求。

輔助生殖技術的日益普及是推動這項成長要素。實驗室技術的進步、臨床療效的提升以及公眾對生育治療方案認知的不斷提高，使得人工授精和體外受精（IVF）等生育治療手段的獲取變得越來越便捷。為了滿足日益成長的患者數量和對專業生殖保健服務的需求，全球生育中心也持續擴張。

幹細胞衍生精子生成和再生醫學領域的技術進步正進一步推動市場擴張。研究機構和生技公司正大力投資利用多功能細胞生成類精子細胞的研發。在美國、歐洲和亞洲進行的成功臨床前試驗表明，該技術在未來應用於治療嚴重男性不孕症患者的臨床應用方面取得了令人矚目的進展。

政府為改善生育治療服務可近性、擴大輔助生殖技術（ART）保險覆蓋範圍而採取的措施也促進了市場成長。此外，醫療保健領域的投資增加、生育意識宣傳計畫以及一些國家出生率下降引發的人口結構問題，都在推動生育治療的普及。

然而，該市場面臨研發高成本、科學要求複雜以及生殖生物技術法規結構嚴格等挑戰。圍繞實驗室培育生殖細胞的倫理問題以及商業化週期長也可能限制市場成長。儘管如此，生殖醫學的持續創新和對生育治療日益成長的需求預計將在預測期內創造顯著的成長機會。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數分析了人工精子市場主要公司的概況：公司概況、服務組合、主要發展、財務表現和策略。
透過利用本報告中的見解，行銷負責人和經營團隊將能夠就未來的服務創新、市場擴張和策略合作夥伴關係做出明智的決策。
《人工精子市場》報告的目標受群眾外包括投資者、服務供應商、製藥公司、監管機構和金融分析師等各類相關人員。
相關人員可以利用系統分析框架和策略矩陣來評估人工精子市場，從而獲得巨大的利益。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

熱圖分析
市佔率分析
公司簡介
- University of California San Diego School of Medicine
- Kallistem
- Nanjing Medical University
- Institute of Zoology, Chinese Academy of Sciences
分析師意見

第8章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI4278

Artificial Sperm Market is estimated to be valued at USD 2.6 Bn in 2026 and is expected to reach USD 4.2 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.6 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.10%	2033 Value Projection:	USD 4.2 Bn

The market is witnessing significant growth driven by the increasing prevalence of infertility worldwide, growing acceptance of assisted reproductive technologies (ART), rising demand for fertility treatments, delayed parenthood trends, and ongoing advancements in reproductive biotechnology and regenerative medicine.

Artificial sperm technology represents an emerging field within reproductive medicine focused on developing functional sperm cells through stem cell technologies and advanced laboratory techniques. The technology has the potential to address severe male infertility conditions such as azoospermia and spermatogenic disorders where conventional fertility treatments may be ineffective. Growing investments in stem cell research and reproductive genetics are accelerating scientific progress and expanding future commercialization opportunities.

The increasing adoption of in vitro fertilization (IVF), artificial insemination, and other ART procedures is creating a favorable environment for the development of artificial sperm technologies. According to the International Committee for Monitoring Assisted Reproductive Technologies (ICMART), more than 13 million babies have been born globally through IVF procedures, highlighting the expanding role of reproductive technologies in fertility care. Furthermore, the expansion of fertility clinics, rising healthcare expenditure, and supportive fertility treatment programs are expected to strengthen market growth over the forecast period.

Market Dynamics

The Artificial Sperm Market is experiencing robust growth due to several demographic, clinical, and technological factors. One of the primary drivers is the increasing burden of infertility globally. According to the World Health Organization (WHO), approximately 17.5% of adults worldwide experience infertility during their lifetime, equivalent to nearly one in six individuals. The rising prevalence of infertility among both men and women continues to create demand for advanced reproductive solutions.

Another significant growth factor is the increasing adoption of assisted reproductive technologies. Fertility treatments such as artificial insemination and IVF have become increasingly accessible due to advancements in laboratory techniques, improved clinical outcomes, and growing public awareness regarding infertility treatment options. Fertility centers continue to expand globally to accommodate rising patient volumes and increasing demand for specialized reproductive healthcare services.

Technological advancements in stem cell-derived sperm development and regenerative medicine are further supporting market expansion. Research institutions and biotechnology companies are investing heavily in the development of sperm-like cells generated from pluripotent stem cells. Successful preclinical studies conducted in the United States, Europe, and Asia have demonstrated promising progress toward future clinical applications for patients suffering from severe male infertility.

Government initiatives aimed at improving access to fertility care and increasing insurance coverage for ART procedures are also contributing to market growth. Growing healthcare investments, fertility awareness programs, and demographic concerns related to declining birth rates in several countries are encouraging broader adoption of fertility treatments.

However, the market faces challenges associated with the high cost of research and development, complex scientific requirements, and stringent regulatory frameworks governing reproductive biotechnology. Ethical concerns surrounding laboratory-generated gametes and long commercialization timelines may also restrict market growth. Nevertheless, continuous innovation in reproductive medicine and increasing demand for fertility treatments are expected to create substantial growth opportunities during the forecast period.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Artificial Sperm Market based on the following parameters - company highlights, service portfolio, key developments, financial performance, and strategies
Key companies covered as a part of this study include University of California San Diego School of Medicine, Kallistem, Nanjing Medical University and Institute of Zoology, Chinese Academy of Sciences
Insights from this report would allow marketers and management authorities to make informed decisions regarding future service innovations, market expansion, and strategic partnerships
The Artificial Sperm Market report caters to various stakeholders including investors, service providers, pharmaceutical companies, regulatory bodies, and financial analysts
Stakeholders would benefit from structured analytical frameworks and strategy matrices used in evaluating the Artificial Sperm Market

Market Segmentation

By Application (Revenue, USD Bn, 2026-2033)
Artificial Insemination
Azoospermia
Others
By End User (Revenue, USD Bn, 2026-2033)
Hospitals
Fertility Centers
Others
By Region: (Revenue, USD Bn, 2026-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
University of California San Diego School of Medicine
Kallistem
Nanjing Medical University
Institute of Zoology, Chinese Academy of Sciences

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Artificial Sperm Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Artificial Insemination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Azoospermia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Artificial Sperm Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Fertility Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Artificial Sperm Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- University of California San Diego School of Medicine
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Kallistem
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Nanjing Medical University
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Institute of Zoology, Chinese Academy of Sciences
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views